A Method for Estimating the Cost- Effectiveness of Incorporating Patient Preferences into Practice Guidelines

Many clinical practice guidelines fail to account for the preferences of the individual patient. Approaches that seek to include the preferences of the individual patient in the decision- making process (e.g., interactive videodisks for patient education), however, may incur sub stantial incremental costs. Developers of clinical practice guidelines must therefore determine whether it is appropriate to make their guidelines flexible with regard to patient preferences. The authors present a formal method for determining the cost-effectiveness of incorporating the preferences of individual patients into clinical practice guidelines. Based on utilities assessed from 37 patients, they apply the method in the setting of mild hypertension. In this example, they estimate that the cost-effectiveness ratio for individualized utility assessment is $48,565 per quality-adjusted year of life, a ratio that compares favorably with other health interventions that are promoted actively. This approach, which can be applied to any clinical domain, offers a formal method for determining whether the incorporation of individual patient preferences is important clinically and is justified economically. Key words: cost-effective ness analysis; cost-utility analysis; utility assessment; decision analysis; practice guidelines; patient preferences. (Med Decis Making 1994;14:382-392)

[1]  Harold C. Sox,et al.  Variation in Patient Utilities for Outcomes of the Management of Chronic Stable Angina: Implications for Clinical Practice Guidelines , 1995 .

[2]  W Sumner,et al.  U-titer: a utility assessment tool. , 1991, Proceedings. Symposium on Computer Applications in Medical Care.

[3]  J. Cutler,et al.  The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. , 1988, Archives of internal medicine.

[4]  Solid Recommendations from Soft Numbers , 1987, Medical decision making : an international journal of the Society for Medical Decision Making.

[5]  J. Neumann,et al.  Theory of games and economic behavior , 1945, 100 Years of Math Milestones.

[6]  R. Brook,et al.  Practice guidelines and practicing medicine. Are they compatible? , 1989, JAMA.

[7]  D K Owens,et al.  Development of outcome-based practice guidelines: a method for structuring problems and synthesizing evidence. , 1993, The Joint Commission journal on quality improvement.

[8]  J. Wennberg,et al.  Multivariate Prediction of In‐Hospital Mortality Associated With Coronary Artery Bypass Graft Surgery , 1992 .

[9]  D. Warner North,et al.  A Tutorial Introduction to Decision Theory , 1968, IEEE Trans. Syst. Sci. Cybern..

[10]  D Weber,et al.  Anatomy of a decision. , 1986, Healthcare forum.

[11]  B. McNeil,et al.  Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. , 1981, The New England journal of medicine.

[12]  R. Fletcher,et al.  Clinical practice guidelines. , 1990, Annals of internal medicine.

[13]  M. Weinstein,et al.  Clinical Decision Analysis , 1980 .

[14]  G. Oster,et al.  Primary prevention and coronary heart disease: the economic benefits of lowering serum cholesterol. , 1986, American journal of public health.

[15]  B. McNeil,et al.  Fallacy of the five-year survival in lung cancer. , 1978, The New England journal of medicine.

[16]  D M Eddy Clinical decision making: from theory to practice. Designing a practice policy. Standards, guidelines, and options. , 1990, JAMA.

[17]  C. Hennekens,et al.  The community-based randomized trials of pharmacologic treatment of mild-to-moderate hypertension. , 1988, American journal of epidemiology.

[18]  J. Cutler,et al.  The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. , 1986, Progress in cardiovascular diseases.

[19]  B. Littenberg,et al.  Screening for hypertension. , 1970, Lancet.

[20]  L. Goldman,et al.  Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. , 1990, JAMA.